GlassScriptPhysician profile
Gregory V Mcintosh
NPI 1184688665
$8,283.82
in general payments reported to CMS, 2019-2025
44 companies · $1,801 in 2025
The $1,801 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,401 · 2020: $369 · 2021: $271 · 2022: $835 · 2023: $1,198 · 2024: $1,408 · 2025: $1,801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,368 · Education: $39.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,367.51 |
| Education | $39.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $808.71 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Ferring Pharmaceuticals INC. | $725.59 | 2019-2025 | Adstiladrin |
| Janssen Biotech, INC. | $667.43 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Pfizer INC. | $658.08 | 2019-2025 | |
| Coloplast Corp | $561.23 | 2019-2023 | Porges Coloplast |
| Sumitomo Pharma America, INC. | $537.35 | 2023-2025 | Orgovyx, Gemtesa |
| Teleflex LLC | $517.04 | 2021-2023 | Urolift |
| Allergan, INC. | $367.72 | 2019-2021 | |
| Dendreon Pharmaceuticals LLC | $265.42 | 2023-2025 | Provenge |
| Merck Sharp & Dohme LLC | $253.97 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Myriad Genetic Laboratories, INC. | $251.13 | 2021-2025 | Prolaris |
| Abbvie INC. | $194.17 | 2022-2025 | |
| Biotissue Holdings INC. | $191.04 | 2025 | |
| Boston Scientific Corporation | $189.72 | 2019-2025 | Ams 700 |
| Procept Biorobotics Corporation | $189.60 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Mcintosh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.